Parkinson's disease, dopamine pathways, movement disorders, and neuroprotection
125 Artikel
A liver enzyme released during exercise may rejuvenate brain blood vessels and protect against cognitive decline and Alzheimer's pathology.
A comprehensive review examines how marine-derived bioactives like omega-3s, astaxanthin, and polysaccharides may combat chronic neuroinflammation underlying major neurodegenerative diseases.
Erkunden Sie, was tatsächlich in Ihrem Gehirn passiert, wenn Sie älter werden – von schrumpfenden Neuronennetzwerken bis hin zu veränderten Botenstoffen – und entdecken Sie, warum manche Menschen bis weit in ihre 80er Jahre und darüber hinaus geistig fit bleiben.
New review maps how α-synuclein assays may detect Parkinson's before symptoms appear — and what stands between lab and clinic.
A new Cell Metabolism study reveals how oxidative stress triggers astrocytes to produce collagen, forming barriers that kill neurons after stroke.
A landmark review argues neurodegeneration is driven by interacting misfolded proteins, not single culprits — reshaping diagnosis and treatment.
A new AI classifier using just 15 proteins achieves 95.5% AUC accuracy across Alzheimer's, Parkinson's, FTD, and Lewy body dementia.
NYU professor Scott Galloway and Andrew Huberman unpack what it takes for men to build meaning, health, and economic stability today.
Neuroscientist Dr. Tommy Wood breaks down diet, exercise, supplementation, and cognitive stimulation strategies to protect brain health across your lifespan.
New research links early dopamine neuron dysfunction in the entorhinal cortex to memory loss in Alzheimer's — and L-DOPA reversed it in mice.
First 6-month RCT shows PAP therapy meaningfully improves MoCA scores and motor function in Parkinson's patients with OSA.
New review reveals how protein clumps and cellular powerhouses work together to drive neurodegeneration in Parkinson's disease.
